Seres Therapeutics, Inc. - COMMON STOCK (MCRB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q3 2025

Type / Class
Equity / COMMON STOCK
Symbol
MCRB on Nasdaq
Shares outstanding
8,667,871
Price per share
$14.65
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,125,842
Total reported value
$40,902,370
% of total 13F portfolios
0%
Share change
-159,011
Value change
-$2,393,659
Number of holders
32
Price from insider filings
$14.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 3.1% -43% $3,377,609 -$2,827,043 268,704 -46% FMR LLC 30 Jun 2025

As of 30 Sep 2025, 32 institutional investors reported holding 2,125,842 shares of Seres Therapeutics, Inc. - COMMON STOCK (MCRB). This represents 25% of the company’s total 8,667,871 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) together control 25% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Flagship Pioneering Inc. 13% 1,155,850 0% 7.6% $22,238,554
VANGUARD GROUP INC 3.6% 311,889 +6.8% 0% $6,000,745
MARSHALL WACE, LLP 1.4% 125,600 +37% 0% $2,416,543
BlackRock, Inc. 1.2% 102,060 +0.7% 0% $1,963,635
Vontobel Holding Ltd. 1.1% 98,511 +23% 0.01% $1,895,352
GEODE CAPITAL MANAGEMENT, LLC 0.98% 84,982 -7.2% 0% $1,635,753
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.36% 31,403 -10% 0% $604,194
CITADEL ADVISORS LLC 0.36% 30,885 0% $594,227
STATE STREET CORP 0.34% 29,731 +11% 0% $572,024
Schonfeld Strategic Advisors LLC 0.33% 28,942 0% $556,843
Lion Point Capital, LP 0.31% 27,138 +59% 3% $522,135
J. Goldman & Co LP 0.31% 27,000 0.02% $519,480
MORGAN STANLEY 0.21% 18,334 +134% 0% $352,746
UBS Group AG 0.15% 12,682 +68% 0% $244,002
NORTHERN TRUST CORP 0.14% 12,101 -20% 0% $232,824
Invesco Ltd. 0.12% 10,442 0% $200,904
BANK OF AMERICA CORP /DE/ 0.06% 5,343 +2773% 0% $102,799
SBI Securities Co., Ltd. 0.04% 3,482 0% 0% $66,994
SIMPLEX TRADING, LLC 0.03% 2,807 0% $54,000
CITIGROUP INC 0.03% 2,621 +29022% 0% $50,428
FMR LLC 0.02% 1,882 -99% 0% $36,209
BARCLAYS PLC 0.02% 1,408 0% $27,090
ROYAL BANK OF CANADA 0% 287 -96% 0% $6,000
BNP PARIBAS FINANCIAL MARKETS 0% 212 0% 0% $4,079
Physician Wealth Advisors, Inc. 0% 142 0% 0% $2,733

Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 2,125,842 $40,902,370 -$2,393,659 $19.24 32
2025 Q2 2,284,946 $25,385,817 +$24,555,434 $11.11 33
2025 Q1 145,407 $101,799 +$101,799 $0.70 4